Ambrx Biopharma Inc. (NYSE: AMAM) started the day on March 16, 2023, with a price decrease of -4.07% at $10.13. During the day, the stock rose to $10.53 and sunk to $9.59 before settling in for the price of $10.56 at the close. Taking a more long-term approach, AMAM posted a 52-week range of $0.38-$13.07.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -301.70%. This publicly-traded company’s shares outstanding now amounts to $38.62 million, simultaneously with a float of $5.52 million. The organization now has a market capitalization sitting at $358.10 million. At the time of writing, stock’s 50-day Moving Average stood at $4.15, while the 200-day Moving Average is $2.45.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 81 employees. It has generated 243,343 per worker during the last fiscal year. Meanwhile, its income per employee was -243,486. The stock had 49.45 Receivables turnover and 0.23 Total Asset turnover. For the Profitability, stocks gross margin was +94.55, operating margin was -101.91 and Pretax Margin of -99.75.
Ambrx Biopharma Inc. (AMAM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. According to the most recent insider trade that took place on Mar 16, this organization’s 10% Owner bought 500,000 shares at the rate of 10.15, making the entire transaction reach 5,074,250 in total value, affecting insider ownership by 53,500,000. Preceding that transaction, on Mar 15, Company’s 10% Owner bought 250,000 for 10.60, making the whole transaction’s value amount to 2,648,875. This particular insider is now the holder of 53,000,000 in total.
Ambrx Biopharma Inc. (AMAM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2022, the organization reported -$1.33 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.09) by -$1.24. This company achieved a net margin of -100.06 while generating a return on equity of -42.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Ambrx Biopharma Inc.’s EPS decrease for this current 12-month fiscal period is -301.70% and is forecasted to reach -0.23 in the upcoming year.
Ambrx Biopharma Inc. (NYSE: AMAM) Trading Performance Indicators
Let’s observe the current performance indicators for Ambrx Biopharma Inc. (AMAM). It’s Quick Ratio in the last reported quarter now stands at 4.70. The Stock has managed to achieve an average true range (ATR) of 1.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 68.86.
In the same vein, AMAM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.26, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of Ambrx Biopharma Inc. (AMAM)
If we take a close look at the recent performances of Ambrx Biopharma Inc. (NYSE: AMAM), its last 5-days Average volume was 1.91 million that shows plunge from its year to date volume of 5.54 million. During the previous 9 days, stock’s Stochastic %D was recorded 61.87% While, its Average True Range was 1.63.
Raw Stochastic average of Ambrx Biopharma Inc. (AMAM) in the period of the previous 100 days is set at 76.83%, which indicates a major rise in contrast to 64.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 325.88% that was lower than 438.40% volatility it exhibited in the past 100-days period.